Jabra Enhance Select 300 vs JLab Hear OTC
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Jabra Enhance Select 300
The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 out of 65 OTC hearing aids tested, placing it in the top 25% of its category. In our standardized testing, speech clarity in quiet environments stands out as a notable strength, scoring 3.6/5—a solid result that sits 0.85 points above the category average. Feedback handling is excellent at 5.0/5, meaning users should experience stable performance without whistling during typical wear. Own-voice comfort also performs well at 3.5/5, nearly a full point above average, which can contribute to a more natural listening experience. Speech understanding in noisy environments presents a limitation, scoring 1.5/5—essentially at the category average but low in absolute terms. This is a common challenge across OTC devices, though users seeking strong noise performance may want to compare alternatives. Music streaming scores 2.6/5, which is above the category average by 0.68 points but mixed in absolute quality. The Enhance Select 300 offers rechargeable batteries and streaming compatibility with both iPhone and Android devices, along with hands-free functionality. It has earned Expert's Choice Awards in both 2023 and 2024. Shoppers in this price range should note that alternatives like the Lucid Tala and Audicus Omni 2 score higher overall, while options like the Jabra Enhance Pro 20 at Costco offer similar sound quality at a lower price point. This device is best suited for those prioritizing speech clarity in quieter settings and stable, feedback-free performance.

JLab Hear OTC
The JLab Hear OTC is a budget-friendly OTC hearing aid priced at $100, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This visible-in-ear device ranks #36 of 65 OTC hearing aids tested, placing it in the top 54% of its category. In our testing, the JLab Hear OTC shows a distinctive performance profile with clear strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling also performs excellently at 5.0/5, providing stable amplification without whistling during our standardized challenge motions. These strengths make it particularly well-suited for users who prioritize streaming audio content. However, speech performance presents limitations. Speech in quiet scores 2.1/5, which is 0.67 points below the category average of 2.79. Speech in noise is more constrained at 1.0/5, falling 0.46 points below average. Own-voice comfort also scores low at 1.8/5, which is 0.71 points below the category norm. These results suggest the device may be less effective for primary speech amplification needs compared to alternatives in its price range. The JLab Hear OTC includes rechargeable batteries and supports both iPhone and Android streaming with hands-free functionality. At this price point, competitors like the Elehear Beyond (4.36/5) and Apple AirPods Pro 2 (4.06/5) offer stronger overall sound performance. This device may appeal most to budget-conscious users who value excellent streaming quality and feedback stability over speech enhancement capabilities.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Audio scenes
Using MUSHRA scenes (Tuned)
Fitting configuration for tuned fit